Back
Construction Partners, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
8
ROAD
Construction Partners, Inc.
Last Price:
$106.08
Seasonality Move:
8.26%
Sell
17
NONOF
Novo Nordisk A/S
Last Price:
$35.59
Seasonality Move:
4.8%
Sell
8
Construction Partners, Inc. (ROAD)
is a Sell
Is Construction Partners, Inc. a Buy, Sell or Hold?
-
The current Construction Partners, Inc. [ROAD] share price is $105.89. The Score for ROAD is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
ROAD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ROAD Stock Price Chart
What is Construction Partners, Inc.'s stock price today?
-
The Construction Partners, Inc. share price today is $105.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROAD is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $35.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
ROAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.27 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -772788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.38 - 127.18) | Sell |
| Bollinger Bands (100): | (105.5 - 124.98) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 34 | Sell |
| Chaikin Money Flow: | -84014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 38.44) | Sell |
| Bollinger Bands (100): | (39.64 - 55.38) | Sell |
ROAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.62 | Sell |
| 20-day SMA: | 113.83 | Sell |
| 50-day SMA: | 121.16 | Sell |
| 200-day SMA: | 114.98 | Sell |
| 8-day EMA: | 109.94 | Sell |
| 20-day EMA: | 114.14 | Sell |
| 50-day EMA: | 117.68 | Sell |
| 200-day EMA: | 111.79 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Sell |
| 20-day SMA: | 37 | Sell |
| 50-day SMA: | 44.15 | Sell |
| 200-day SMA: | 53.01 | Sell |
| 8-day EMA: | 35.83 | Sell |
| 20-day EMA: | 37.34 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 54.32 | Sell |
Construction Partners, Inc. Earnings Growth & ROAD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.45 per share, an increase this year of $0.76 per share, and an increase next year of $0.79 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Construction Partners, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||